Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Enzymatic Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102888431A reveals high-concentration enzymatic synthesis for L-tert-Leucine, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN112538506A details a novel lipase-catalyzed route for Chloramphenicol Succinate, offering higher purity, reduced toxicity, and scalable manufacturing for global supply chains.
Patent CN114921507B reveals lipase resolution for 2-oxabicyclo-[3.3.0]oct-6-en-3-one. High purity, green process, reliable supply chain for pharmaceutical intermediates.
Patent CN106222218B reveals green enzymatic route for salidroside. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Novel bioenzymatic route for high-purity pseudouridine. Reduces cost and environmental impact for pharmaceutical intermediates manufacturing.
Patent CN117025574A reveals high-activity dipeptidase for L-Carnosine. Green enzymatic route offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel enzymatic process ensures 95-100% purity. Reduces oxidation risks and offers scalable solutions for nutritional ingredients manufacturing.
Patent CN101104861B reveals a novel Yarrowia lipolytica lipase method for S-ibuprofen. Discover cost-effective, high-selectivity biocatalysis for pharmaceutical manufacturing.
Patent CN101475968B reveals lipase-catalyzed synthesis. High purity, mild conditions. Ideal for pharma and nutrition supply chains seeking green alternatives.
Patent CN102586384B reveals a novel deracemization method for D-amino acids using Alcaligenes faecalis, offering high optical purity and simplified downstream processing for pharmaceutical supply chains.
Patent CN101914595A reveals enzymatic route for ferulic acid sugar esters offering green manufacturing advantages and supply chain stability for global pharmaceutical intermediates procurement.
Patent CN109369631B details a novel enzymatic route for LDHA inhibitor intermediates, offering high ee values and scalable manufacturing for reliable pharmaceutical suppliers.
Patent CN109180496B details a novel lipase-catalyzed resolution and Mitsunobu reaction for Cinacalcet. Achieve high purity without hazardous reducing agents.
Patent CN109609475A reveals mutant dehydrogenase for high-purity L-Glufosinate-ammonium. Offers scalable agrochemical intermediate manufacturing with reduced waste.
Patent CN112159831B reveals cost-effective enzymatic NMN synthesis. Discover supply chain advantages and high-purity manufacturing capabilities for global buyers.
Patent CN102876759A details a chemo-enzymatic NAD preparation method offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN109852593B details a high-activity CmCR mutant for R-3HB production, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN110317849B reveals a high-yield enzymatic method for producing chiral tetrahydroisoquinoline intermediates, offering significant cost and purity advantages for pharmaceutical manufacturing.
Patent CN1425019A discloses a novel enzymatic route for vitamin D precursors, offering cost reduction in pharmaceutical intermediates manufacturing through scalable crystallization.
Novel chemo-enzymatic route for diabetes drug intermediate offers high purity and scalable manufacturing solutions for global pharmaceutical supply chains efficiently.